The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...
Conroe-based bio-tech company VGXI Inc. has defaulted on its tax abatement agreement with Montgomery County and will pay more ...
Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the TD Cowen ...
Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata” or the "Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
Motherly on MSN
A teacher used a vase to explain grief to her fourth graders—and parents everywhere are learning from it
When Ryan Brazil told her students, “We make space for each other,” she offered a truth that extends well beyond her ...
THIRD QUARTER IN BRIEFActive Biotech provided status update for the development of laquinimod in inflammatory eye disorders and tasquinimod in hematological malignancies (July 8)Active Biotech present ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using ...
Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...
Vir Biotechnology, Inc. ( ($VIR) ) has released its Q3 earnings. Here is a breakdown of the information Vir Biotechnology, Inc. presented to its ...
IM1240, the first CAPTN-3 tri-specific antibody targeting the novel tumor-associated antigen 5T4, advances toward first-in-human clinical trials, with an Investigational New Drug (IND) submission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback